Skip to main content
. 2013 Feb 26;3(2):e233. doi: 10.1038/tp.2012.150

Table 2. Demographics and descriptive RVP analysis for HC and AD groups, with ANCOVA and ROC analysis.

  Healthy control Alzheimer's disease P-value FDR adj. P ROC: AUC% (s.d.%)
Number of participants (N) 123 25      
Age: years (mean (s.d.)) 71.6 (5.6) 72.4 (7.5) 0.557a    
Gender; Males: (N (%)) 55 (45) 12 (48) 0.764b    
Hypertension: (N (%)) 44 (36) 11 (44) 0.439b    
Diabetes: (N(%)) 6 (5) 2 (8) 0.533b    
History of Smoking: (N(%)) 5 (4) 2 (8) 0.407b    
APOE ε4 Carrier: (N (%)) 38 (31) 14 (56) 0.019b    
CRVE (mean (s.d.)) 182.7 (15.8) 169.7 (15.3) 0.000256c 0.0049d 0.703 (0.067)
FDv (mean (s.d.)) 1.210 (0.05) 1.171 (0.048) 0.000350c 0.0033d 0.716 (0.074)
BSTDa (mean (s.d.)) 4.101 (0.504) 4.538 (0.984) 0.00135c 0.0086d 0.595 (0.070)
BSTDv (mean (s.d.)) 3.983 (0.575) 4.433 (1.333) 0.00188c 0.0089d 0.541 (0.081)
Num1stBv (mean (s.d.)) 3.618 (1.052) 2.960 (1.136) 0.00560c 0.021d 0.660 (0.121)
Num1stBa (mean (s.d.)) 3.675 (1.075) 3.040 (0.978) 0.00710c 0.022d 0.675 (0.142)
FDa (mean (s.d.)) 1.235 (0.052) 1.201 (0.061) 0.00799c 0.021d 0.644 (0.075)
CRAE (mean (s.d.) 129.1 (10.3) 122.9 (12.4) 0.0115c 0.027d 0.612 (0.082)
AFa (mean (s.d.)) 0.778 (0.086) 0.824 (0.081) 0.0176c 0.037d 0.578 (0.081)
BCv (mean (s.d.)) 1.253 (0.165) 1.347 (0.240) 0.0186c 0.035d 0.556 (0.084)
Tortv ( × 10−5) (mean (s.d.)) 7.660 (1.554) 6.952 (2.601) 0.0244c 0.042d 0.706 (0.073)
AFv (mean (s.d.)) 0.701 (0.097) 0.748 (0.095) 0.0301c 0.047d 0.616 (0.074)
LDRa (mean (s.d.)) 17.05 (7.87) 21.72 (9.55) 0.0333c 0.049d 0.651 (0.068)
JEv (mean (s.d.)) −0.110 (0.378) −0.272 (0.338) 0.0483c 0.066d 0.539 (0.074)

Only RVPs that were significantly different between groups (P<0.05) in ANCOVA analysis are shown. Significant results after FDR adjustment shown in bold type.

Classification accuracy of RVP parameters from ROC analysis, AUC (area under the curve): AUC=0.5 implies random separation of groups, AUC=1.0 implies perfect separation.

Refer to Table 1 for a description of the retinal vascular parameters.APOE ε4 carrier status refers to carrier/non-carrier of an Apolipoprotein E e4 allele.

a

Analysis of variance (ANOVA) for the continuous age demographic variable (P<0.05 considered significant).

b

χ2 test for categorical demographic variables (gender, hypertension, diabetes, smoking status and APOE ε4 carrier status) (P<0.05 considered significant).

c

P-value from ANCOVA analysis of differences between groups (including confounders).

d

ANCOVA P-values adjusted for false discovery rate (FDR) (P<0.05 considered significant).